Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Which drug for what patient with heart failure, and when?
G. S. Francis
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Which drug for what patient with heart failure, and when?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
Patients with Heart Failure
100%
Heart Failure
66%
Heart Failure Therapy
66%
Therapeutic Strategies
66%
Left Ventricular Dysfunction
66%
Angiotensin-converting Enzyme Inhibitor (ACEi)
66%
Vasodilator
33%
Congestive Heart Failure
33%
Beta-blockers
33%
Public Health Risk
33%
Preventive Treatment
33%
High Mortality
33%
Diuretics
33%
Investigational Agents
33%
Antiarrhythmic Agents
33%
Digitalis
33%
Cardiac Dilation
33%
Inotropic Agents
33%
β-agonists
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Clinical Trial
50%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Heart Left Ventricle Failure
33%
Beta Adrenergic Receptor Blocking Agent
16%
Beta Adrenergic Receptor Stimulating Agent
16%
Inotropic Agent
16%
Heart Dilatation
16%
Antiarrhythmic Agent
16%
Diseases
16%
Diuretics
16%
Investigational Agent
16%